Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

Available commercial assays may yield inaccurate hepatitis C virus (HCV) genotype assignment in up to 10% of cases. We investigated the cost-effectiveness of re-evaluating HCV genotype by population sequencing, prior to choosing a direct acting antiviral (DAA) regimen. Between March and September 20...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clinicoecon Outcomes Res
Autores principales: Polilli, Ennio, Cento, Valeria, Restelli, Umberto, Ceccherini-Silberstein, Francesca, Aragri, Marianna, Di Maio, Velia Chiara, Sciacca, Antonina, Santoleri, Fiorenzo, Fazii, Paolo, Costantini, Alberto, Perno, Carlo Federico, Parruti, Giustino
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028103/
https://ncbi.nlm.nih.gov/pubmed/27695353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S106238
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares